1028634-76-5 Usage
Uses
Used in Sleep Regulation:
C36H50N6O5 is used as a sleep aid for individuals suffering from insomnia, jet lag, or irregular sleep patterns, such as night shift workers. It helps regulate the body's natural sleep-wake cycle, promoting restful sleep.
Used in Anti-Cancer Applications:
Melatonin, with its C36H50N6O5 molecular structure, is studied for its potential anti-cancer properties. It may help modulate various oncological signaling pathways, exerting inhibitory effects on tumor growth and progression.
Used in Anti-Inflammatory Applications:
C36H50N6O5 is also being researched for its potential anti-inflammatory properties, which could contribute to the management of various inflammatory conditions.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, C36H50N6O5 is used as an active ingredient in the development of medications aimed at improving sleep quality and potentially treating certain health conditions related to its antioxidant and anti-inflammatory properties.
Used in Dietary Supplements:
C36H50N6O5 is used as a dietary supplement to support healthy sleep patterns and overall well-being, particularly for those experiencing sleep disturbances or seeking to enhance their antioxidant defenses.
Check Digit Verification of cas no
The CAS Registry Mumber 1028634-76-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,8,6,3 and 4 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1028634-76:
(9*1)+(8*0)+(7*2)+(6*8)+(5*6)+(4*3)+(3*4)+(2*7)+(1*6)=145
145 % 10 = 5
So 1028634-76-5 is a valid CAS Registry Number.
1028634-76-5Relevant academic research and scientific papers
Process for the preparation of atazanavir
-
Page/Page column 7, (2008/12/06)
The invention relates to a process for the preparation of Atazanavir, which comprises reacting the hydrochloride salt of compound (6) with N-methoxycaxbonyl-L-tert-leucine, the removal of the benzyloxycarbonyl group and the reaction with methoxycarbonyl chloride. The process is particularly advantageous in that it allows to use reduced amounts of N-methoxycarbonyl-L-tert-leucine and avoids the use of unstable intermediates.
